Click-based Portfolio

A portfolio of diagnostic tests combining speed and accuracy

Our Click chemistry-based portfolio focuses on the diagnosis of Legionnaires’ Disease (C4Legio LFA), urinary tract infections (C4UTI) and the development of antimicrobial susceptibility tests (C4AST). 

As Click-chemistry technology is robust and versatile, we intend to develop a full AST product line and address other therapeutic areas targeting other micro-organisms.

Our tests sharing the Click-chemistry technology combine speed & accuracy. This key feature brings leverage to fight antimicrobial resistance, which is one the biggest challenge humanity faces.